TR200003224T2 - İyi huylu prostat hiperplasianın tedavisinde alfa 1A reseptörü antagonistleri olarak yararlı olan ftalimido arilpiperazinler - Google Patents

İyi huylu prostat hiperplasianın tedavisinde alfa 1A reseptörü antagonistleri olarak yararlı olan ftalimido arilpiperazinler

Info

Publication number
TR200003224T2
TR200003224T2 TR2000/03224T TR200003224T TR200003224T2 TR 200003224 T2 TR200003224 T2 TR 200003224T2 TR 2000/03224 T TR2000/03224 T TR 2000/03224T TR 200003224 T TR200003224 T TR 200003224T TR 200003224 T2 TR200003224 T2 TR 200003224T2
Authority
TR
Turkey
Prior art keywords
alpha
treatment
benign prostatic
prostatic hyperplasia
useful
Prior art date
Application number
TR2000/03224T
Other languages
English (en)
Inventor
Gee-Hong Kuo
V. Murray William
P. Prouty Catherine
Original Assignee
Ortho-Mcneil Pharmaceutical,Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ortho-Mcneil Pharmaceutical,Inc filed Critical Ortho-Mcneil Pharmaceutical,Inc
Publication of TR200003224T2 publication Critical patent/TR200003224T2/tr

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/44—Iso-indoles; Hydrogenated iso-indoles
    • C07D209/48—Iso-indoles; Hydrogenated iso-indoles with oxygen atoms in positions 1 and 3, e.g. phthalimide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/08—Drugs for disorders of the urinary system of the prostate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/10—Drugs for disorders of the urinary system of the bladder
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Urology & Nephrology (AREA)
  • Diabetes (AREA)
  • Endocrinology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
  • Indole Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

Abstract

Bu bulus bir ftalimido arilpiperazin türevleri serisi, bunlari içeren farmasötik bilesimler ve bunlarin yapiminda kullanilan islemler ve ara-bilesiklerle ilgilidir. Bulusun bilesikleri seçici olarak iyi huylu prostat hiperplasiada mevcut olan bir reseptör olan alfa 1a adrenerjik reseptörüne baglanmayi inhibe eder. Dolayisiyla bilesikler bu hastaligin tedavisinde potansiyel olarak yararlidir.
TR2000/03224T 1998-02-20 1999-02-19 İyi huylu prostat hiperplasianın tedavisinde alfa 1A reseptörü antagonistleri olarak yararlı olan ftalimido arilpiperazinler TR200003224T2 (tr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US7551098P 1998-02-20 1998-02-20

Publications (1)

Publication Number Publication Date
TR200003224T2 true TR200003224T2 (tr) 2001-03-21

Family

ID=22126243

Family Applications (1)

Application Number Title Priority Date Filing Date
TR2000/03224T TR200003224T2 (tr) 1998-02-20 1999-02-19 İyi huylu prostat hiperplasianın tedavisinde alfa 1A reseptörü antagonistleri olarak yararlı olan ftalimido arilpiperazinler

Country Status (21)

Country Link
US (2) US20020077476A1 (tr)
EP (1) EP1056720B1 (tr)
JP (1) JP2002503722A (tr)
KR (1) KR100608473B1 (tr)
CN (1) CN1172911C (tr)
AR (1) AR015521A1 (tr)
AT (1) ATE280156T1 (tr)
AU (1) AU766411B2 (tr)
BR (1) BR9908122A (tr)
DE (1) DE69921300T2 (tr)
ES (1) ES2233023T3 (tr)
HK (1) HK1031872A1 (tr)
HU (1) HUP0100704A3 (tr)
IL (2) IL137953A0 (tr)
NO (1) NO317104B1 (tr)
NZ (1) NZ506461A (tr)
PL (1) PL194649B1 (tr)
PT (1) PT1056720E (tr)
TR (1) TR200003224T2 (tr)
WO (1) WO1999042445A1 (tr)
ZA (1) ZA991319B (tr)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ITMI20010164A1 (it) * 2001-01-30 2002-07-30 Recordati Chem Pharm Alfa 1 antagonisti selettivi a + d
CN103387531A (zh) * 2012-05-10 2013-11-13 广州医学院 酰胺类芳基哌嗪衍生物及其制备方法和在抗良性前列腺增生中的应用
HUP1400294A2 (hu) 2014-06-13 2015-12-28 Skillpharm Kft Clopidogrel új alkalmazása
CN106966940B (zh) * 2015-07-30 2019-03-19 新发药业有限公司 一种西他列汀磷酸盐中间体n-芳甲基-2s-氰基甲基吖啶的制备方法

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1382742A (en) 1972-09-19 1975-02-05 Labaz Benzofuran derivatives and process for preparing the same
CH585693A5 (tr) 1974-02-08 1977-03-15 Ciba Geigy Ag
HU177702B (en) 1977-10-24 1981-12-28 Noevenyvedelmi Kutato Intezet Plant growth regulator and process for preparing the active materials
PT82077B (fr) * 1985-02-26 1987-09-25 Sanofi Sa Procede pour l'obtention des derives aminoalcools peptidiques inhibiteurs de la renine et des proteases acides
FR2678271B1 (fr) * 1991-06-27 1995-01-13 Synthelabo Derives de pyrimidine-4-carboxamide, leur preparation et leur application en therapeutique.
US5428037A (en) * 1993-04-09 1995-06-27 Syntex Pharmaceuticals, Ltd. Heterocyclic derivatives in the treatment of Ischaemia and related diseases
DE69818255T2 (de) * 1997-05-12 2004-12-23 Ortho-Mcneil Pharmaceutical, Inc. Arylsubstituierte piperazine die bei der behandlung von gutartiger prostatischer hyperlasie nützlich sind

Also Published As

Publication number Publication date
AU766411B2 (en) 2003-10-16
CN1172911C (zh) 2004-10-27
ZA991319B (en) 2000-11-20
US20030088099A1 (en) 2003-05-08
EP1056720B1 (en) 2004-10-20
US20020077476A1 (en) 2002-06-20
NO20004142L (no) 2000-10-19
HUP0100704A2 (hu) 2001-10-28
DE69921300D1 (de) 2004-11-25
BR9908122A (pt) 2001-11-13
AR015521A1 (es) 2001-05-02
US6780994B2 (en) 2004-08-24
EP1056720A1 (en) 2000-12-06
WO1999042445A1 (en) 1999-08-26
KR20010041118A (ko) 2001-05-15
IL137953A (en) 2006-12-31
HK1031872A1 (en) 2001-06-29
KR100608473B1 (ko) 2006-08-09
CN1291185A (zh) 2001-04-11
ATE280156T1 (de) 2004-11-15
DE69921300T2 (de) 2006-03-09
PL194649B1 (pl) 2007-06-29
HUP0100704A3 (en) 2002-10-28
NO20004142D0 (no) 2000-08-18
AU2776599A (en) 1999-09-06
IL137953A0 (en) 2001-10-31
PT1056720E (pt) 2005-02-28
PL342357A1 (en) 2001-06-04
NO317104B1 (no) 2004-08-09
NZ506461A (en) 2003-08-29
ES2233023T3 (es) 2005-06-01
JP2002503722A (ja) 2002-02-05

Similar Documents

Publication Publication Date Title
TR200100149T2 (tr) Dual anjiyotensin endotelin alıcı antagonistleri olarak bifenil-sülfonamitler
TR200100299T2 (tr) Tedavi edici biaril türevleri.
TR200100267T2 (tr) İkameli anilid bileşimleri ve yöntemler.
TR199802136T2 (tr) IMPDH enzimi inhibitörleri olarak üre türevleri.
TR200102029T2 (tr) 1-Heterosiklil ikameli diarilaminler.
TR200001218T2 (tr) İkameli karboksamidotiazoller, bunların üretimi ve bunları içeren farmasötik bileşimler.
NO20034230D0 (no) 1,2,3,4-tetrahydroisokinolin-derivater som urotensin II reseptor-antagonister
TR200101961T2 (tr) 1,2-halkalı kinolin türevleri
TR200200768T2 (tr) Yeni kuinüklidin türevleri ve bunu içeren ilaç bileşimleri
NO20024339D0 (no) 1,2,3,4-Tetrahydroisokinolin-derivater
BR9806752A (pt) Ftalazinonas.
TR200003377T2 (tr) Estrojenler ile bütünleşik 2-fenil-1-[4-(2-aminoetoksi)benzil]-indol
TR200002877T2 (tr) Sülfonamid türevleri
TR200103396T2 (tr) Anti-fas antikoru içeren farmasötik terkipler.
TR200200359T2 (tr) Cgrp Antagonist'lerinin ve cgrp-release (Gevşeme)-Engelleyici Menopoza Bağlı Deri Kızarıklıklarında Kullanılması
TR199701645A2 (tr) Vitronektin reseptör antagonistleri,bunlarin imalati ve kullanimi
TR199902971T2 (tr) Selim prostat hiperplazisinin tedavisinde yararli aril ikameli piperazinler.
TR200003220T2 (tr) İyi huylu prostat hiperplasianın tedavisinde yararlı olan yeni sübstitüe edilmiş piridino arilpiperazinler
TR200003224T2 (tr) İyi huylu prostat hiperplasianın tedavisinde alfa 1A reseptörü antagonistleri olarak yararlı olan ftalimido arilpiperazinler
DK1273572T3 (da) Thiophensubstituerede piperaziner anvendelige til behandling af binign prostatisk hyperplasi
DE69831737D1 (de) Neurotrypsin
TR200001173T2 (tr) Antiviral proteaz inhibitörleri
TR200100363T2 (tr) Vitronektin reseptör antagonistleri.
ATE291587T1 (de) Somatostatin analoge und deren verwendung zur behandlung von krebs
EP1346983A3 (en) Phthalimido arylpiperazines as alpha 1A receptor antagonists useful in the treatment of benign prostatic hyperplasia